Respiratory Agents Flashcards
Pulmonary SNS Stimulation
Bronchial smooth muscle relaxation
Bronchodilation via β2 receptors
Pulmonary PSNS Stimulation
Vagus nerve
Bronchial smooth muscle constriction
Bronchoconstriction via muscarinic M3 receptors
↑secretions
Asthma
Chronic airway inflammatory disorder
↑responsiveness to tracheobronchial tree stimuli
Bronchial hypersensitivity/reactivity to irritant stimuli
T2 lymphocytes activation & cytokine release
REVERSIBLE airway obstruction
COPD
Emphysema/bronchitis
IRREVERSIBLE obstruction
Cell death & alveolar destruction d/t impaired lung parenchyma, degraded membranes, & inflammatory cell toxic actions
Enlarged air spaces, fibrosis, & ↑mucus production
Medications to Treat Obstructive Disorders
- Short-acting bronchodilators
- Regular inhaled corticosteroids
- Long-acting bronchodilators
- PDEi, methylxanthines, leukotriene inhibitors
- Oral corticosteroid
- Cromolyns
Medications to Treat Obstructive Disorders
- Short-acting bronchodilators
- Regular inhaled corticosteroids
- Long-acting bronchodilators
- PDEi, methylxanthines, leukotriene inhibitors
- Oral corticosteroid
- Cromolyns
Bronchodilators
β adrenergic agonists
Anticholinergics
Methylxanthines
β Adrenergic Agonists
Epinephrine β1&2 α
Isoproterenolα β1&2
Metaproterenolα β1&2
β2 > β1
200-400x
Short-Acting β Adrenergic Agonists
Terbutaline
Albuterol
Levalbuterol
Salbutamol
Long-Acting β Adrenergic Agonists
Salmeterol
β Adrenergic Agonists MOA
β adrenergic receptors are coupled to stimulatory G proteins
Activate adenyl cyclase ↑cAMP production → bronchodilation
↓intracellular Ca2+ release & alters the membrane conductance
- Smooth muscle relaxation & bronchodilation
- Inhibits mediators released from mast cells
- ↑mucus clearance by ciliary action
β Adrenergic Agonists Onset
RAPID w/in minutes
Ideal rescue inhaler
β Adrenergic Agonists DOA
Short
4-6 hours
β Adrenergic Agonists
Side Effects
Tremors
↑HR
Vasodilation
Metabolic changes - hyperglycemia, hypokalemia, & hypomagnesemia
*Minimized via inhalation delivery
Albuterol
Short-acting β adrenergic agonist 2 isomers - R-albuterol levalbuterol ↑β2 affinity - S-albuterol ↑β1 affinity 100mcg/puff via MDI 2 puffs Q4-6H Nebulizer 2.5-5mg in 5mL NS
Albuterol DOA
4 up to 8 hours
Albuterol
Anesthetic Implications
Additive effects w/ volatile anesthetics
↑bronchodilation
Albuterol Side Effects
Tachycardia
Hypokalemia
4 puffs to blunt airway responses to tracheal intubation in asthmatic patients
Terbutaline
β adrenergic agonist Pediatric SQ 0.01mg/kg Adult SQ 0.25mg Q15min MDI 16-20puffs/day 200mcg per dose
Salmeterol
Long-acting β agonist
Combination w/ Fluticasone (Flonase) steroid
Lipophilic side chains resist degradation
DOA 12-24 hours
Prevention NOT acute flare-u